BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/12/2025

FDA Clears EFFEXOR XR for Continued Sale

The FDA has determined that the 100mg EFFEXOR XR extended-release capsule was not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications for the product.

Source: Federal Register — Food and Drug AdministrationOpen original release →